MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Has $9.21 Million Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH trimmed its position in DocuSign, Inc. (NASDAQ:DOCU) by 1.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 148,314 shares of the company’s stock after selling 2,615 shares during the quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH’s holdings in DocuSign were worth $9,209,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Dakota Wealth Management grew its position in shares of DocuSign by 0.8% during the 2nd quarter. Dakota Wealth Management now owns 23,022 shares of the company’s stock worth $1,232,000 after buying an additional 181 shares during the period. Sovereign Financial Group Inc. grew its holdings in DocuSign by 4.3% during the 3rd quarter. Sovereign Financial Group Inc. now owns 4,487 shares of the company’s stock worth $279,000 after acquiring an additional 184 shares during the period. Elo Mutual Pension Insurance Co raised its position in shares of DocuSign by 1.1% during the 2nd quarter. Elo Mutual Pension Insurance Co now owns 18,848 shares of the company’s stock valued at $1,008,000 after acquiring an additional 214 shares during the last quarter. Motley Fool Asset Management LLC raised its position in shares of DocuSign by 6.0% during the 1st quarter. Motley Fool Asset Management LLC now owns 3,960 shares of the company’s stock valued at $236,000 after acquiring an additional 224 shares during the last quarter. Finally, Optimist Retirement Group LLC lifted its stake in shares of DocuSign by 5.6% in the 2nd quarter. Optimist Retirement Group LLC now owns 4,255 shares of the company’s stock valued at $228,000 after purchasing an additional 227 shares during the period. 77.64% of the stock is owned by institutional investors.

DocuSign Trading Down 0.5 %

Shares of NASDAQ DOCU opened at $68.89 on Monday. The company has a fifty day moving average price of $58.30 and a 200 day moving average price of $56.82. The firm has a market cap of $14.10 billion, a PE ratio of 132.48, a PEG ratio of 7.33 and a beta of 0.92. DocuSign, Inc. has a 1-year low of $38.11 and a 1-year high of $69.78.

DocuSign (NASDAQ:DOCU) last posted its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.17. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The company had revenue of $736.03 million during the quarter, compared to analysts’ expectations of $727.20 million. During the same period in the prior year, the firm earned $0.09 earnings per share. DocuSign’s revenue for the quarter was up 7.0% compared to the same quarter last year. Equities research analysts forecast that DocuSign, Inc. will post 1.01 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently commented on DOCU shares. Wells Fargo & Company upped their price objective on DocuSign from $48.00 to $50.00 and gave the company an “underweight” rating in a report on Friday, September 6th. Bank of America upped their price target on DocuSign from $60.00 to $68.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Royal Bank of Canada lifted their price objective on shares of DocuSign from $52.00 to $57.00 and gave the stock a “sector perform” rating in a research note on Friday, September 6th. JMP Securities reaffirmed a “market outperform” rating and issued a $84.00 target price on shares of DocuSign in a research note on Thursday, September 5th. Finally, Citigroup lifted their price target on shares of DocuSign from $86.00 to $87.00 and gave the stock a “buy” rating in a research report on Friday, September 6th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $63.40.

Insider Transactions at DocuSign

In other news, Director Daniel D. Springer sold 287,052 shares of the business’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $53.78, for a total value of $15,437,656.56. Following the sale, the director now owns 923,445 shares of the company’s stock, valued at $49,662,872.10. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, Director Teresa Briggs sold 534 shares of the stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $56.56, for a total transaction of $30,203.04. Following the completion of the transaction, the director now directly owns 7,202 shares in the company, valued at $407,345.12. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Daniel D. Springer sold 287,052 shares of DocuSign stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $53.78, for a total value of $15,437,656.56. Following the completion of the sale, the director now directly owns 923,445 shares in the company, valued at approximately $49,662,872.10. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 418,002 shares of company stock valued at $22,471,973 in the last ninety days. 1.66% of the stock is currently owned by corporate insiders.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.